These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4999633)

  • 41. [Ethambutol combined with streptomycin and isoniazid for the original treatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hayashi N; Hibino S
    Kekkaku; 1970 Feb; 45(2):55-60. PubMed ID: 5439133
    [No Abstract]   [Full Text] [Related]  

  • 42. Study on Mycobacterium tuberculosis: the primary drug resistance pattern.
    Siddique MA; Rahman KM; Muazzam N; Hossain T; Islam KM; Rahman MA; Chowdhury FA; Ali CM
    Bangladesh Med Res Counc Bull; 1995 Apr; 21(1):18-23. PubMed ID: 7575339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of low-frequency ultrasound on Mycobacterium tuberculosis].
    Shaĭkhaev AIa; Makarevich NM
    Probl Tuberk; 1989; (10):43-6. PubMed ID: 2512572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 46. A comparative study of the susceptibility to major and minor drugs of tubercle bacilli isolated from 100 consecutive patients never treated with minor drugs.
    Tan THIAM HOK ; The KIE SENG ; Yang SHE YEN ; Tan LIOE SAN
    Paediatr Indones; 1966; 6(2):71-4. PubMed ID: 4960067
    [No Abstract]   [Full Text] [Related]  

  • 47. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo].
    Belogurova VP; Gorislavets II; Ivanitskaia NN
    Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
    J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The clinical significance of the critical drug resistance concentration of SM,INH and PAS].
    Baba H; Azuma Y
    Kekkaku; 1972 Oct; 47(10):353-60. PubMed ID: 4658707
    [No Abstract]   [Full Text] [Related]  

  • 50. The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. II. Antituberculosis activity of INH and SM in vitro after exposure to PAS.
    Maekawa N; Nakanishi ; Kawai M; Ikeda N; Nakai H
    Kekkaku; 1971 Aug; 46(8):293-4. PubMed ID: 4998861
    [No Abstract]   [Full Text] [Related]  

  • 51. Initial and acquired drug resistance of Mycobacterium tuberculosis in east Delhi.
    Mahajan M; Agarwal DS; Gadre DJ; Singh NP; Gupta HC; Talwar V
    J Commun Dis; 1996 Mar; 28(1):15-9. PubMed ID: 8778175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 53. [Determination of drug resistance of Mycobacterium tuberculosis by methods of proportions and absolute concentrations].
    Golyshevskaia VI; Sevast'ianova EV; Voronina GA
    Probl Tuberk; 2001; (3):51-3. PubMed ID: 11508236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 56. [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
    Güneri S; Unsal I; Oztop A; Erkut M; Avkan Oğuz V; Ozgü A; Cakmak R
    Mikrobiyol Bul; 2004 Jul; 38(3):203-12. PubMed ID: 15490839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of 4-chloroanilid of 5-chlorosalicylic acid on the viability of tubercle bacilli in vitro].
    Kostrzeński W; Paklerska-Pobratyn H
    Gruzlica; 1968 Feb; 36(2):161-4. PubMed ID: 4969840
    [No Abstract]   [Full Text] [Related]  

  • 58. [Niacin test for differentiation of Mycobacterium tuberculosis var. hominis from other acid-fast bacilli. 8. Significance of growth condition and resistance to the primary antituberculous drugs in niacin test].
    Ogawa T; Iizukam
    Kekkaku; 1968 Jan; 43(1):17-27. PubMed ID: 4970421
    [No Abstract]   [Full Text] [Related]  

  • 59. [METHOD FOR EVALUATING THE STRENGTH OF SYNTHETIC ANTIBIOTICS IN THE BLOOD SERUM DURING CHEMOTHERAPY OF TUBERCULOSIS].
    OKAMOTO K; FUJINAGA R; YAMAUCHI H
    Kekkaku; 1963 Sep; 38():413-7. PubMed ID: 14056005
    [No Abstract]   [Full Text] [Related]  

  • 60. [Resistance of Mycobacterium tuberculosis to antituberculotic drugs in Czech Republic in 2003].
    Homolka J; Krejbich F; Havelková M
    Cas Lek Cesk; 2004; 143(12):836-9. PubMed ID: 15730215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.